University of Porto   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Porto Portugal (1836)

Organization Overview

First Clinical Trial
2011
NCT01580943
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Andreia Vieira | Bravo, Jorge, PhD | Center of Psychology at University of Porto | CINTESIS, Faculty of Medicine of the University of Porto | CINTESIS - Faculty of Medicine of University of Porto | Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine of the University of Porto | Faculdade de Desporto, Universidade do Porto | Faculdade de Medicina, Universidade do Porto | Faculty of Medicine of University of Porto | Gastrenterologist | Institute of Public Health of the University of Porto (ISPUP) | Instituto de Patologia e Imunologia Molecular da Universidade do Porto | Instituto de Saude Publica da Universidade do Porto | Medical Faculty of University of Porto | Mota, Jorge, PhD, University of Porto | NOVA CRU, NOVA Medical School | NOVA Medical School | Universidade do Porto

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Diseases (Phase 3)

Brain Injuries (Phase 3)

Dental Plaque (Phase 2)

Hemorrhoids (Phase 3)

Hypoxia (Phase 3)

Hypoxia, Brain (Phase 3)

Hypoxia-Ischemia, Brain (Phase 3)

Infant, Newborn, Diseases (Phase 3)

Insulin Resistance (Phase 2)

Ischemia (Phase 3)

Metabolic Syndrome (Phase 2)

Neoplasms, Germ Cell and Embryonal (Phase 2)

Overweight (Phase 1)

Pain, Postoperative (Phase 4)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 24
  • # of Trial APIs: 24